Regulatory Approvals

Tauklarify’s approval comes as the Alzheimer’s diagnostics field increasingly explores less invasive approaches, particularly blood-based tests for phosphorylated tau (pTau).

Polaroid Therapeutics designed POLTX_Fibers™ to help reduce infection risk while supporting wound healing at the point of care.

Lyme disease is transmitted primarily through the bites of infected ticks.

The summit will examine reforms covering healthcare financing, primary and specialised care, health commodities, digital health, the health workforce, and maternal and newborn health.

If approved and launched, the vaccine will complement CanSinoBIO’s recently approved three-component DTaP vaccine, Tripecia® (DT3cP Infant), expanding the company’s pertussis-containing vaccine portfolio across age groups.

The approval allows the company’s PGDx elio tissue complete CDx to be used in hospitals and clinical laboratories across the United States to help identify patients who may benefit from targeted treatment.

The approval from the Medicines and Healthcare products Regulatory Agency (MHRA) marks another milestone in the rapidly growing market for oral weight-loss medicines.

The approval expands Orzeyful’s commercial reach following its authorization in China in July 2026, marking another milestone in Takeda’s global launch strategy.

The partnership will support Nigeria’s post-marketing vaccine surveillance system by evaluating innovative screening devices and expanding routine laboratory testing for vaccine lots.

The decision follows the failure of the phase 3 Lagoon trial, which did not meet its primary endpoint of overall survival.